en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2007
vol. 45
 
Share:
Send email
Share:
abstract:

The consensus on rituximab administration in the treatment of patients with rheumatoid arthritis

Jacek Szechliński
,
Piotr Głuszko
,
Eugeniusz Józef Kucharz
,
Włodzimierz Maśliński
,
Włodzimierz Samborski
,
Witold Tłustochowicz
,
Piotr Wiland

Reumatologia 2007; 45, 3: 115–119
Online publish date: 2007/07/02
View full text Get citation
 
Rituximab is a biologic B-cell targeted treatment in rheumatoid arthritis. A present consensus statement was formulated in order to determine indications and contraindications of using rituximab in rheumatoid arthritis. This statement was established based on data from randomized controlled trials on haematology and rheumatology. Rituximab in combination with methotrexate constitutes a major advance in the treatment of adult patients with rheumatoid arthritis who have had inadequate response or intolerance of disease modifying anti-rheumatic drugs (DMARDs) including one or more TNF-blocking agents.
keywords:

rheumatoid arthritis, lymphocyte B, rituximab
EVENTS/KONFERENCJE
BOOKS/KSIĄŻKI



Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.